Celyad Oncology SA Operating Expenses 2011-2026 | CYAD

Annual Operating Expenses Celyad Oncology SA

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	26.2 M	29.4 M	34.5 M	29.8 M	34.7 M	29.8 M	19.9 M	8.66 M	-5.19 M	3.31 M

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
34.7 M	-5.19 M	21.1 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 4.55	-0.66 %	$ 10.9 B	Australia
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	20.7 M	$ 0.91	3.25 %	$ 6.69 M	China
Compugen Ltd. CGEN	40.4 M	$ 2.59	-5.13 %	$ 242 M	Israel
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	708 M	$ 22.53	-0.62 %	$ 3.73 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Avenue Therapeutics ATXI	4.49 M	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioNTech SE BNTX	512 M	$ 100.76	-1.27 %	$ 27.2 B	Germany
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Inventiva S.A. IVA	36.2 M	$ 4.94	-1.4 %	$ 138 M	France
Aquestive Therapeutics AQST	85.5 M	$ 4.06	-0.86 %	$ 434 M	USA
Arcutis Biotherapeutics ARQT	137 M	$ 22.64	-2.81 %	$ 2.88 B	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.42	-4.39 %	$ 378 M	Britain
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.97	2.06 %	$ 4.89 M	Israel
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	26.7 M	-	-3.03 %	$ 260 M	USA
CASI Pharmaceuticals CASI	38.9 M	-	-	$ 35.4 M	USA
BioXcel Therapeutics BTAI	107 M	$ 1.03	-2.83 %	$ 12.6 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Cabaletta Bio CABA	172 M	$ 2.79	-2.62 %	$ 280 M	USA